QA: Metavia Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2020_Metavia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 10, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 2}}

Graph

Absolute values for 0001638287, Metavia Inc

  xvar xval
0 AssetsCurrent 14,118,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 200,000
3 remainder_Assets 150,000
4 LiabilitiesCurrent 2,082,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 94,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense -2,762,188
9 ResearchAndDevelopmentExpense 17,288,381
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,775,807
13 remainder_ComprehensiveNetIncome 9,991
  yvar yval
0 Assets 14,468,000
1 Liabilities 2,176,000
2 Expenses 14,526,193
3 Revenues 0
4 StockholdersEquity 12,292,000
5 NetIncome -16,302,000
6 ComprehensiveNetIncome -16,297,004
7 BaseVar 16,477,996
8 EconomicCapitalRatiobeforeLimitedLiability 1.26
9 EconomicCapitalRatio 2.50

Edgar->Model Mapping

Feature Distribution

Change over Time